Teva Pharmaceuticals (TEVA) Stock
Fundamentals
Latest news
About Teva Pharmaceuticals
In a complex world, Teva's mission is simple: to be a global leader in genetics and biopharmaceuticals, improving the lives of patients across the world. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health. We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio is among the largest of any pharmaceutical company in the world. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard D. Francis | President, CEO & Director | 1968 |
| Mr. Eliyahu Sharon Kalif | Executive VP & CFO | 1974 |
| Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer | 1970 |
| Ms. Christine Fox | Executive VP of US Commercial & Head of Innovative Franchise | 1969 |
| Mr. Evan Lippman M.B.A. | Executive Vice President of Business Development | 1970 |
| Mr. Matthew Shields | Executive Vice President of Global Operations | 1975 |
| Mr. Amir Weiss | Senior VP & Chief Accounting Officer | 1977 |
| Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |